scanX
Home
Ind Swift Laboratories

Ind Swift Laboratories

130.77
-0.96
(-0.73%)
Market Cap (₹ Cr.)
₹777
52 Week High
186.00
Book Value
₹
52 Week Low
81.85
PE Ratio
5.83
PB Ratio
0.83
PE for Sector
38.54
PB for Sector
4.67
ROE
%
ROCE
67.05 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
6.89 %
Net Income Growth
781.13 %
Cash Flow Change
-183.81 %
ROE
545.10 %
ROCE
363.49 %
EBITDA Margin (Avg.)
6.69 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
158
177
167
154
161
184
170
179
176
168
188
171
222
207
178
249
205
187
200
204
197
210
227
227
220
248
237
248
296
279
295
311
278
305
278
283
794
42
Expenses
189
146
136
126
137
154
140
146
149
148
155
133
170
149
128
159
149
144
159
157
149
161
173
173
177
191
175
189
241
219
231
246
207
239
207
222
309
35
EBITDA
-31
31
31
28
24
30
30
33
27
20
33
39
52
58
49
89
56
43
41
47
47
49
54
54
44
57
62
60
56
60
64
64
71
65
71
61
484
7
Operating Profit %
-29 %
14 %
16 %
16 %
15 %
14 %
16 %
15 %
12 %
10 %
16 %
20 %
21 %
17 %
19 %
19 %
22 %
21 %
16 %
20 %
19 %
21 %
22 %
22 %
19 %
21 %
24 %
22 %
13 %
20 %
20 %
18 %
23 %
20 %
23 %
20 %
19 %
-15 %
Depreciation
33
21
21
21
21
22
22
22
22
22
21
22
21
25
25
25
28
23
23
23
22
20
20
20
28
14
14
21
82
16
16
15
13
14
13
14
13
0
Interest
31
26
26
24
37
25
23
21
20
21
19
17
-28
5
22
22
27
28
29
29
21
25
25
25
24
24
24
24
23
24
24
22
21
20
21
21
-11
0
Profit Before Tax
-95
-16
-16
-17
-34
-17
-14
-9
-16
-23
-7
0
59
28
1
42
1
-8
-10
-5
4
4
9
9
-9
19
24
15
-50
20
24
26
36
31
36
27
483
6
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
11
0
0
0
25
0
0
-3
6
14
6
5
144
0
Net Profit
-71
-16
-16
-17
-10
-17
-14
-9
0
-23
-7
0
48
28
1
42
-20
-8
-11
-5
3
4
9
9
-29
19
24
15
-63
20
24
29
30
17
30
22
350
6
EPS in ₹
-17.31
-3.98
-3.83
-4.23
-2.33
-4.08
-3.52
-2.02
0.10
-5.13
-1.65
0.02
10.63
6.08
0.29
9.11
-4.01
-1.70
-2.29
-1.05
0.59
0.71
1.56
1.56
-4.91
3.17
4.04
2.52
-10.69
3.41
4.07
4.95
5.09
2.89
5.09
3.66
59.17
1.05
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,238
2,210
2,121
1,997
1,913
1,860
1,817
1,803
1,788
1,105
Fixed Assets
1,114
1,095
1,042
934
913
843
752
629
587
8
Current Assets
906
909
807
809
817
845
866
998
1,074
546
Capital Work in Progress
115
82
70
69
20
11
19
10
8
0
Investments
0
0
26
26
26
26
55
111
85
166
Other Assets
1,009
1,033
982
968
953
979
991
1,052
1,108
931
Total Liabilities
1,646
1,696
1,595
1,454
1,322
1,216
1,179
1,170
1,113
183
Current Liabilities
830
949
994
920
342
309
287
314
350
178
Non Current Liabilities
816
746
601
534
980
906
892
857
763
4
Total Equity
592
515
526
543
590
645
639
633
675
922
Reserve & Surplus
551
473
480
497
542
585
579
573
616
863
Share Capital
42
42
45
46
48
60
60
60
60
59
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
3
-7
-8
23
-20
1
-1
1
416
Investing Activities
-37
-30
-31
-17
-2
-10
-10
3
-14
-104
Operating Activities
100
80
93
71
-75
123
135
136
183
-180
Financing Activities
-64
-48
-69
-62
100
-133
-124
-140
-168
700
Above figures are in Rs. Crores

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Promoter
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
42.00 %
FIIs
0.37 %
0.17 %
0.05 %
0.01 %
0.22 %
0.06 %
0.00 %
0.00 %
0.04 %
0.00 %
0.08 %
0.17 %
0.31 %
0.25 %
1.26 %
0.85 %
DIIs
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
19.49 %
18.73 %
8.03 %
0.94 %
0.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
38.14 %
38.34 %
38.46 %
38.50 %
38.29 %
38.44 %
38.50 %
38.50 %
38.47 %
38.50 %
38.43 %
38.33 %
38.95 %
49.72 %
55.80 %
56.21 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,898.40 4,48,867.59 42.57 49,887.17 12.06 9,648 42.62 73.07
Cipla
1,621.80 1,32,699.41 29.85 26,520.66 14.17 4,155 17.77 48.91
Dr Reddys Laboratories
6,744.40 1,11,701.59 20.07 28,905.40 12.36 5,578 -0.90 52.63
Mankind Pharma
2,685.15 1,08,123.84 55.10 10,615.63 19.57 1,942 9.89 69.14
Zydus Life Science
1,068.00 1,06,987.83 25.66 19,831.50 13.82 3,831 30.78 36.40
Lupin
2,188.15 1,01,202.24 44.71 20,141.50 19.94 1,936 77.69 51.87
Aurobindo Pharma
1,515.30 89,528.49 24.96 29,559.25 17.55 3,169 61.17 49.98
Alkem Laboratories
6,197.15 74,427.42 34.62 12,978.42 9.84 1,811 91.18 57.49
Glenmark Pharmaceuticals
1,678.30 47,658.76 - 12,653.09 6.58 -1,831 96.52 52.73
Biocon
372.85 44,584.28 28.57 15,621.20 35.25 1,298 478.78 53.36

Corporate Action

Technical Indicators

RSI(14)
Neutral
36.78
ATR(14)
Less Volatile
7.45
STOCH(9,6)
Oversold
9.62
STOCH RSI(14)
Oversold
1.17
MACD(12,26)
Bearish
-1.42
ADX(14)
Weak Trend
23.74
UO(9)
Bullish
29.64
ROC(12)
Downtrend And Accelerating
-10.17
WillR(14)
Oversold
-96.40
Bearish
3
Neutral
3
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Price & Volume Screeners
Fundamental Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.